Assignee
DART NEUROSCIENCE CAYMAN LTD
US·25 granted patents·5 pending applications·47 citations·filing 2010–2019
Top patents by PatentIndex Score
30 records- 0194US9175010B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Nov 3, 2015·12 cites·17 claims
- 0289US9284335B2Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disordersDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Mar 15, 2016·5 cites·26 claims
- 0388US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0487US9650349B2Therapeutic isoxazole compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted May 16, 2017·3 cites·18 claims
- 0587US9533996B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0686US9499562B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2013·Granted Nov 22, 2016·3 cites·27 claims
- 0784US10092575B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 9, 2018·3 cites·10 claims
- 0881US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 0979US10239882B2Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Mar 26, 2019·2 cites·20 claims
- 1078US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1178US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 1277US9708334B2Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jul 18, 2017·2 cites·20 claims
- 1376US9150572B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Oct 6, 2015·2 cites·3 claims
- 1476US9102674B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Aug 11, 2015·2 cites·35 claims
- 1574US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 1672US9675605B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jun 13, 2017·1 cites·7 claims
- 1771US10376514B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 1865US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 1964US10053467B2Therapeutic isoxazole compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted Aug 21, 2018·0 cites·20 claims
- 2064US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 2163US9624200B2Therapeutic piperazinesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2014·Granted Apr 18, 2017·0 cites·21 claims
- 2262US10105367B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 2362US9863934B2Screening methods for cognitive enhancersDART NEUROSCIENCE (CAYMAN) LTD·Filed 2016·Granted Jan 9, 2018·0 cites·15 claims
- 2461US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 2560US2014038945A1Piperazine pde4 inhibitors and uses thereofDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Application pending·0 cites
- 2659US9956213B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted May 1, 2018·0 cites·18 claims
- 2749US2013189314A1Enteric-coated ht-2157 compositions and methods of their useDART NEUROSCIENCE CAYMAN LTD·Filed 2012·Application pending·0 cites
- 2847US8343957B2Therapeutic pyrazoloquinoline urea derivativesDART NEUROSCIENCE CAYMAN LTD·Filed 2010·Granted Jan 1, 2013·0 cites·14 claims
- 2936US10040759B2Substituted azetidinyl compounds as GlyT1 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Aug 7, 2018·0 cites·20 claims
- 3033US2017273968A1Mao-b inhibitors and rehabilitationDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DART NEUROSCIENCE CAYMAN LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →